Clinical Trial Results: Mantle Cell Lymphoma

Product Name: MabThera/Rituxan [rituximab]
Date of Report: 12/1/2004
Phase: IV
Treatment of Mantle Cell Non Hodgkin’s Lymphoma with Rituximab after Autologous Marrow or Peripheral Blood Stem Cell Transplantation

Product Name: MabThera/Rituxan [rituximab]
Date of Report: To be Published
Phase: II
A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.

Product Name: MabThera/Rituxan [rituximab]
Date of Report: 8/7/2007
Phase: II
In vivo purging with High Dose Sequential chemotherapy and Rituximab monoclonal antibody (R-HDS), in newly diagnosed mantle cell lymphoma.